Features to report - cystectomy (total / partial), cystoprostatectomy, pelvic exenteration

Topic Completed: 1 May 2011

Minor changes: 22 November 2019

Copyright: (c) 2002-2019,, Inc.

PubMed Search: Cystectomy (total / partial) [title] OR cystoprostatectomy [title] OR pelvic exenteration [title]

Monika Roychowdhury, M.D.
Page views in 2019: 244
Page views in 2020 to date: 98
Cite this page: Roychowdhury M Features to report - cystectomy (total / partial), cystoprostatectomy, pelvic exenteration. website. Accessed June 3rd, 2020.
Definition / general
  • Editor's note
  • Mandatory / optional are for accreditation purposes by the American College of Surgeons Committee on Cancer

  • Recommended to include clinically relevant historical information (Virchows Arch 2004;445:103)

  • Specimen type / procedure
  • Tumor size
  • Tumor histologic type
  • Tumor histologic grade
  • Adequacy of specimen to determine muscularis propria invasion (muscularis propria found / not found / indeterminate)
  • Lymphovascular invasion (present / absent / indeterminate)
  • Pathologic stage (includes depth of invasion) (pTNM)
  • Regional lymph nodes: either no nodes submitted or found, number examined / cannot be determined (explain), number involved (any size) / cannot be determined (explain); optional - extranodal extension of tumor
  • Surgical margins: specify margins involved by invasive carcinoma or in situ carcinoma; if uninvolved by invasive carcinoma, specify distance from invasive carcinoma to margin
  • Presence of tumor at margins of urethra, ureter, paravesicular soft tissue or pelvic soft tissue
  • Involvement of adjacent structures: perivesical fat, ureter (specify laterality), urethra, vagina, uterus and adnexae, pelvic sidewall (specify laterality), prostate, seminal vesicle (specify laterality), rectum, other
  • Additional epithelial lesions: papilloma, inverted papilloma, papillary neoplasm of low malignant potential

Optional but recommended:
  • Site of tumor
  • Tumor configuration (papillary, solid / nodule, flat, ulcerated, indeterminate)
  • Additional findings: multifocality, carcinoma in situ, dysplasia, hyperplasia, inflammation, therapy related changes, keratinizing squamous metaplasia, intestinal metaplasia, inflammation / regenerative changes, cystitis cystica glandularis, urothelial carcinoma involving urethra / prostatic ducts and acini (use protocol for carcinoma of urethra)

Back to top